Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
23andme
ancestrydna
artificial intelligence
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
big data
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
clover health
column
digital health
diversity
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
garmin
gene therapy
health
health catalyst
healthcare
healthtech
joshua brumm
kaleido biosciences
life sciences
livongo
machine learning
medical
misfit
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
omron
What
ago
2
×
ipos
2
×
achieve
age
apparently
billion
biotechs
catalyst
combined
considering
data
diseases
drug
dyne
early
expected
experimental
eyes
genetic
glitters
gold
golden
having
health
healthtech
humans
ipo
joint
livongo
long
medicines
million
muscle
raised
rare
reach
reaching
startups
therapeutics
true
Language
unset
Current search:
ipos
×
ago
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
4 years ago
All that glitters is not gold: How healthtech startups can achieve true value